Admelog is a rapid-acting insulin lispro approved by the FDA in 2017 as a follow-on biologic to Humalog. It works the same way as the original Humalog but is usually priced lower, giving people with diabetes a more affordable option for mealtime insulin coverage.
What Makes Admelog a “Follow-On” Insulin
Admelog, manufactured by Sanofi, was approved through the FDA’s 505(b)(2) pathway as a follow-on biologic. This regulatory category is similar to a biosimilar for biologic medications but uses an older approval framework that existed before the modern biosimilar pathway. In practical terms, it means Admelog had to demonstrate equivalent efficacy and safety to the reference product (Humalog).
Unlike generic small-molecule drugs, biologic medications like insulin cannot be exact copies because they are made in living cells. Follow-on biologics and biosimilars are considered highly similar with no clinically meaningful differences. Admelog is not automatically substituted for Humalog at the pharmacy, so a doctor must write the prescription specifically for Admelog.
How Admelog Works
Admelog contains insulin lispro, a rapid-acting insulin analog. The lispro molecule has a slight modification to the human insulin structure (two amino acids are reversed) that prevents the insulin from clumping together in the injection site. This allows it to absorb and act more quickly than regular human insulin.
After injection, Admelog begins working within 15 minutes, reaches peak activity in 1 to 2 hours, and continues acting for about 3 to 5 hours. This fast profile matches the rise in blood sugar that happens after eating, making it ideal for mealtime dosing.
Who Admelog Is For
Admelog is approved for adults and children aged 3 years and older with diabetes who need mealtime insulin. It can be used in type 1 and type 2 diabetes as part of a basal-bolus regimen, where a long-acting insulin covers background needs and rapid-acting insulin covers meals.
For people exploring diabetes treatment options, it is important to understand that insulin lispro is used for established diabetes, not prediabetes. If your A1C is in the prediabetes range, lifestyle changes and sometimes metformin are the usual starting points.
Dosing and Administration
Admelog is injected subcutaneously within 15 minutes before a meal or immediately after starting a meal. The dose depends on your carbohydrate intake, current blood sugar, and individual insulin sensitivity. Your diabetes care team will help calculate an insulin-to-carb ratio and a correction factor for high blood sugars.
Admelog is available in 10 mL vials, 3 mL SoloStar pens, and 3 mL cartridges. It can also be used in insulin pumps for continuous subcutaneous infusion. Injection sites include the abdomen, thighs, upper arms, and buttocks, and sites should be rotated to prevent lipohypertrophy.
| Characteristic | Admelog | Humalog |
|---|---|---|
| Active ingredient | Insulin lispro | Insulin lispro |
| Onset | 15 minutes | 15 minutes |
| Peak | 1-2 hours | 1-2 hours |
| Duration | 3-5 hours | 3-5 hours |
| Typical price per vial (cash) | Lower | Higher |
| Automatic substitution at pharmacy | No | N/A |
Common Side Effects
The side effect profile of Admelog mirrors that of Humalog and other rapid-acting insulins. The most common are:
- Hypoglycemia — Low blood sugar is the most frequent side effect and can be serious if severe.
- Weight gain — Common when starting insulin therapy.
- Injection site reactions — Redness, itching, or mild swelling that typically improves with site rotation.
- Lipohypertrophy — Fatty buildup from repeated injections in the same spot.
- Allergic reactions — Rare but can range from local hives to systemic reactions.
Avoiding Hypoglycemia
Because Admelog acts quickly, hypoglycemia can happen if a meal is delayed, skipped, or smaller than planned after dosing. Exercise can also lower blood sugar more than expected. According to the American Diabetes Association, blood sugar below 70 mg/dL is considered hypoglycemia and should be treated promptly.
The 15-15 rule is the standard approach: consume 15 grams of fast-acting carbohydrate, wait 15 minutes, and recheck. Repeat if needed. Severe hypoglycemia, which involves confusion or loss of consciousness, requires glucagon and emergency care.
Switching Between Admelog and Humalog
Because both products contain the same active ingredient, many people switch between them with minimal adjustment. However, small differences in formulation excipients or manufacturing can occasionally affect how a person responds. The FDA does not classify Admelog as interchangeable with Humalog, meaning a pharmacist cannot substitute one for the other without a new prescription.
If you switch, monitor blood sugar more closely for the first week or two and be ready to fine-tune doses with your diabetes care team. Most people notice no meaningful difference.
Storage and Handling
Unopened Admelog vials, pens, and cartridges should be refrigerated between 36 and 46 degrees Fahrenheit. Once in use, Admelog can be kept at room temperature (below 86 degrees Fahrenheit) for up to 28 days. Never freeze insulin, and keep it away from direct heat and sunlight.
Admelog is a clear, colorless solution. Inspect each dose before injection. If it looks cloudy, discolored, or contains particles, do not use it.
Cost and Insurance Coverage
Admelog was launched specifically to provide a lower-cost alternative to Humalog. Cash prices at major retail pharmacies are typically 15 to 30 percent lower than Humalog, though individual pricing varies. Many insurance plans now cover Admelog on preferred formulary tiers, and Sanofi offers a savings program for eligible patients.
Medicare and Medicaid coverage also apply. The recent federal insulin price cap of 35 dollars per month for Medicare beneficiaries applies to Admelog as well as other covered insulins.
The Bottom Line
Admelog gives people with diabetes a rapid-acting insulin option that performs like Humalog at a typically lower price. For anyone managing the cost of mealtime insulin, Admelog is worth discussing with your healthcare provider. As with any insulin change, work closely with your diabetes team to monitor blood sugar carefully after starting or switching, and make dose adjustments as needed.
